There have been numerous inconclusive studies examining the differences between unexplained and peritoneal endometriosis-associated infertility. Hence, the choice of artificial reproductive technique may be difficult. This prospective study compares outcome in couples with unexplained infertility and with minimal or mild endometriosisassociated infertility, undergoing treatment with ovarian stimulation combined with artificial insemination by husband. No differences were found between the unexplained infertile and the endometriosis group as to patient characteristics, response to ovarian stimulation and semen qualities. There was a significantly higher total pregnancy rate, with more multiple gestations, in the unexplained infertile compared with the endometriosis group. The difference in outcome could reflect differences in pathogenesis and aetiology for the two groups.
Introduction
When investigating infertility, endometriosis is often revealed in otherwise asymptomatic women, and is claimed to be a possible reason for their failure to conceive. Even without adhesions or endometriomas, endometriosis is associated with subfertility. The only difference between unexplained and mild endometriosis-associated infertility is the presence of endometriosis in the latter. However, histologically verified endometriosis has been found in biopsies of visually normal peritoneum from infertile patients (Nisolle et al., 1990) , making the distinction between the two groups dubious. On the other hand, cumulative conception rates in untreated, unexplained and endometriosis-associated infertility seem to indicate that they are two different entities (Hull, 1992) .
The literature is controversial as to the relationship between endometriosis and infertility and it has not yet been established if endometriosis is the cause or the result of infertility, or simply an epiphenomenon (Mahmood and Templeton, 1990) . It is also asserted that endometriosis is a physiological finding, intermittently occurring in most, if not all, menstruating women (Evers, 1994; Koninckx, 1994) . This being the case, unexplained infertility and infertility associated with peritoneal © European Society for Human Reproduction and Embryology endometriosis should be considered equivalent and have the same outcome in an assisted reproduction setting.
When treating unexplained and endometriosis-associated infertility with assisted reproductive techniques, numerous studies have demonstrated similar pregnancy rates after invitro fertilization (IVF) and embryo transfer (French In Vitro National, 1993; Tanbo et al., 1995; Templeton et al., 1996) . Since factors representative of the peritoneal environment are emphasized in the aetiology of endometriosis-associated infertility (Curtis et al., 1993) , a difference between unexplained and endometriosis-associated infertility might be more readily apparent when conception is encouraged in its natural environment. A prospective study by our group, comparing various in-vivo fertilization procedures in cases of non-tubal infertility, indicated a higher pregnancy rate for unexplained infertility compared with endometriosis-associated infertility after ovarian stimulation combined with artificial insemination by husband (AIH) (Åbyholm et al., 1992) . However, the number of subjects in each group was small. Therefore, the study was extended and its emphasis placed on the discovery of possible differences in treatment outcome of AIH in unexplained infertility and in infertility associated with peritoneal endometriosis.
Materials and methods
A prospective cohort study was performed comparing all couples referred to our unit with unexplained or endometriosis-associated infertility who were undergoing their primary cycle of ovarian stimulation combined with AIH from December 1987 to December 1996. The inclusion criteria were: a minimum of 3 years of infertility, regular ovulatory cycles with luteal phase progesterone concentrations and normal prolactin concentrations, normal hysterosalpingogram, normal laparoscopy for the unexplained infertility group and endometriosis stage 1 or 2 without adhesions according to the revised American Fertility Society for the endometriosis group (American Fertility Society, 1985) . Normal semen characteristics in two or more tests (ജ20ϫ10 6 sperm/ml, ജ40% motility, ജ40% normal morphology) were required. Subjects with previous ovarian surgery or who had undergone previous assisted reproductive techniques were excluded from the study. In cases of more than four large follicles on the day of human chorionic gonadotrophin administration (HCG), the cycle was either cancelled or transferred to IVF-embryo transfer from 1990 onwards. Low responders were also cancelled, and a total of 29 initially included patients were thus excluded from the study, 20 with unexplained infertility and nine with endometriosis.
For ovarian stimulation, two different regimens were used: (i) clomiphene citrate (CC: Clomivid ® ; Draco, Lund, Sweden or Pergotime ® ; Serono, Aubonne, Switzerland) 100 mg orally from cycle day 3 for 5 days, followed by daily injections (i.m. or s.c.) of 75-150 IU human menopausal gonadotrophin (HMG; Humegon ® ; Organon, Oss, The Netherlands or Pergonal ® ; Serono), or urofollitrophin [follicle-stimulating hormone (FSH); Fertinorm ® or Fertinorm HP ® ; Serono] from cycle day 7; (ii) HMG or FSH only, starting on cycle day 3. Urofollitrophin was used on a regular basis instead of HMG from 1994. Monitoring of stimulation was performed by regular vaginal ultrasound scans and serum oestradiol measurements. With the CC/HMG or CC/FSH regimen gonadotrophin injections were given for 3-5 days and ovulation induction with HCG (9000 IE Physex ® ; Leo, Ballerup, Denmark or 10 000 IE Profasi ® ; Serono) was induced when at least one follicle had reached a mean diameter of 18 mm, usually on cycle days 11-13. With the gonadotrophin only cycles, HMG or FSH were given for 5-7 days and HCG was administered when the largest follicle had a minimum diameter of 15 mm, cycle days 9-10. Since HCG was administered on different cycle days the two stimulation regimens were used randomly in order to avoid insemination in weekends or on days with expectedly high activity in our IVF programme.
Each sperm sample was mixed with 0.2 ml HEPES medium (250 nM) and liquefied for 20 min at room temperature. Seven µl native semen were evaluated with the HTM-2030 Motility Analyzer ® (Hamilton Thorn Research, Danvers, MA, USA) in micro-cell counting chambers. Because morphological evaluation with this equipment became available to us from early 1992, these data are not given prior to this date. A semen quantity of 0.5 ml was then added to 4-6 pipettes (5 ml, Falcon 2027) containing 2 ml medium (250 nM HEPES) and incubated at 37°C in a 45°oblique position for 1 h. The top 1-1.5 ml were collected in a pipette (15 ml, Falcon 2095) and centrifuged for 5 min by 500 g. The supernatant was immediately removed and the pellet added to 0.5 ml medium for intrauterine insemination (IUI) and 1 ml medium for intraperitoneal insemination (IPI). A sperm count was performed after 15 min in the dark at room temperature, transported to a 2 ml syringe (Discardit II) by suction, the volume registered and the amount reduced before insemination.
All patients received IUI through a TDT catheter (Prodimed, Neuilly-en-Thelle, France) 19-22 h after HCG injection, and IPI 24 h after IUI. However, from 1994 all patients received IUI twice because of similar results and less patient discomfort (Hovatta et al., 1990) . After insemination the women stayed in bed for 30 min and received sick leave for the 2 days of inseminations only. Twelve days after the second insemination, serum β-HCG was measured, and if positive, the women were given an appointment for vaginal ultrasound scanning 5 weeks post-insemination to verify the pregnancy.
Statistics
Data are given as mean Ϯ SD. Student's t-test was used to compare normally distributed continuous variables, while non-parametric data were examined with the Mann-Whitney test. Comparison of categorical variables was performed with the χ 2 test, or the Fisher's exact test in the case of any infrequent response. P values Ͻ 0.05 were considered statistically significant.
Although the design was not a randomized clinical trial but rather a prospective study of two cohorts, a calculation of the number of subjects necessary to achieve statistical significance was performed based on previous results from our group (Åbyholm et al., 1992) . Using one tailed test, α ϭ 0.05 and β ϭ 0.2, the minimum number of subjects was 138.
Results
For patients with unexplained or endometriosis-associated infertility we found no difference in age distribution (31.8 Ϯ 4.0 and 31.3 Ϯ 3.3 years, respectively), duration of infertility (4.8 Ϯ 1.8 and 5.0 Ϯ 1.9 years respectively) or frequency of There was no statistically significant difference between the two groups. FSH ϭ follicle-stimulating hormone; HMG ϭ human menopausal gonadotrophin; HCG ϭ human chorionic gonadotrophin. There was no statistically significant difference between the two groups. primary infertility (69.7 and 75.5% respectively). No difference was found between the two groups as to stimulation regimen, dose of gonadotrophin, oestradiol concentration, days of stimulation and number of follicles prior to insemination (Table I ). All semen insemination characteristics were comparable for the two groups (Table II) . The pregnancy rate was significantly higher for the unexplained infertility group, being 33.3% compared with 16.3% for the endometriosis group (P Ͻ 0.05) (Table III) . Furthermore, an increased number of multiple gestations was obtained in the unexplained infertility group resulting in a significantly higher implantation rate per cycle compared with the endometriosis group.
Discussion
Assisted reproduction includes several treatment options. Depending on the cause of infertility, each couple needs specific advice to choose the most appropriate treatment. In cases of non-tubal infertility the options are many and their choice should be influenced by the probable success rate, the cost and the ethical concerns associated with the various procedures.
Studies comparing different assisted reproduction procedures in cases of non-tubal infertility with normal spermatozoa report various success rates (Tanbo et al., 1990; Tanbo and Åbyholm, 1991; Åbyholm et al., 1992; Simon et al., 1994) . Due to differences in patient selection, stimulation and insemination procedures, the results of homologous insemination vary from pregnancy rates of 2.5-29% per cycle (Åbyholm and Tanbo, 1993) . Results of AIH seem to indicate an inferior outcome for endometriosis-associated infertility compared with unexplained infertility (Chaffkin et al., 1991; Karlstrøm et al., 1993; Åbyholm et al., 1992; Kahn et al., 1992; Isaksson and Tiitinin, 1997) . However, each study contained small groups, especially for endometriosis, and no significant differences were demonstrated. Based on our previous results (Åbyholm et al., 1992) , we decided to extend the study to reveal possible different success rates for homologous insemination in unexplained and endometriosis-associated infertility.
We found a higher pregnancy rate and more implantations per cycle in cases of unexplained infertility compared with infertility associated with peritoneal endometriosis. Since the responses to stimulation and semen parameters were comparable in the two groups, other causal relationships must be sought. Conception in vivo implies several successfully executed reactions: a normal ovulation procedure by which the ovum is expelled from the Graafian follicle and captured by the fimbriae, normal transport mechanisms for both gametes and preimplantation embryos in the Fallopian tube, a favourable environment for fertilization and pre-embryo development and the existence of a receptive endometrium at the time of hatching. Based on our previous experience with IVF (Tanbo et al., 1995) , preimplantation embryo development and implantation are equally successful in cases of unexplained infertility and endometriosis following fertilization in vitro. It is therefore tempting to speculate that the reduced fertility associated with peritoneal endometriosis is caused by processes in vivo related to ovulation or those occurring in the tuboperitoneal environment.
A possible mechanism that might be responsible for both unexplained and endometriosis-associated infertility is luteinized unruptured follicle (LUF) syndrome. Conflicting data on the association of LUF with endometriosis have been reported (Brosens et al., 1978; Vanrell et al., 1982) . However, more recent publications indicate a higher incidence of LUF in patients with than without endometriosis (Yasuyuki et al., 1992) .
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Mechanisms of gamete and pre-embryo transport in the human Fallopian tube are complex. A peritoneal fluid circulating system in the ampulla has been demonstrated (GaddumRosse and Blandau, 1976) . The compelling report of tubal ovum surrogate transport demonstrated that women with unexplained infertility had a lower transport capacity compared to normal controls (Uher et al., 1990) . Results from further studies including cases of endometriosis could give valuable information.
In normal women, peritoneal ectopic endometrium and decaying spermatozoa are probably eliminated by a cellmediated immune response. In women with minimal and mild endometriosis, peritoneal fluid has been shown to prohibit favourable sperm movement (Curtis et al., 1993) and to contain macrophages with increased sperm phagocytotic ability (Muscato et al., 1982) , possibly as an adverse effect to an increased homeostatic reaction, yielding an undesirable gametophobic environment. Immunological disorders found in endometriosis patients rather than in those with unexplained infertility might be a causal connection between endometriosis and infertility (Dmowski et al., 1994; Martinez-Roman et al., 1997) .
The causal relationship between minimal peritoneal endometriosis and subfertility has recently been further substantiated by the results of the Canadian multicentre trial on the effect of laparoscopic surgery for endometriosis-associated infertility (Marcoux et al., 1997) . In this study, the cumulative pregnancy rate was significantly higher in subjects randomized to ablative surgery for endometriosis compared with the no treatment group.
Our study was based on endometriosis diagnosed visually during laparoscopy and classified according to the revised American Fertility Society (rAFS) staging. Employing this widely used diagnostic tool, it is impossible to rule out cases of atypical or non-visual stages of peritoneal endometriosis in any infertility group. This phenomenon might occur frequently in groups of unexplained infertility, being representative of a precursor stage to visible endometriosis (Gleicher, 1994) . It is possible that couples with invisible, but histologically verified, peritoneal endometriosis would behave differently from those with unexplained infertility with a negative biopsy in an assisted reproductive treatment setting. The inevitable mixing of the unexplained infertility group with an unknown number of so-called non-visual endometriosis patients actually strengthens the difference we found.
In conclusion, it seems likely that the difference in outcome reflects a difference in pathogenesis and aetiology for unexplained and endometriosis-associated infertility. For unexplained infertility two to three treatments with IUI prior to IVF seems to be a simple and successful choice and, if pregnancy is not achieved, these patients should subsequently be referred to IVF to rule out a possible fertilization defect. In cases of endometriosis-associated infertility, of stages 1 and 2 without adhesions, IUI may be offered as a treatment option due to its simplicity. In our hands, however, IVF-embryo transfer yields a 10% higher success rate per cycle and therefore is our first choice of treatment for endometriosis-associated infertility (Tanbo et al., 1995) .
